Treace Medical Concepts Inc (TMCI)
5.76
+0.33
(+6.08%)
USD |
NASDAQ |
Nov 05, 16:00
6.70
+0.94
(+16.32%)
After-Hours: 20:00
Treace Medical Concepts Free Cash Flow: -41.50M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -41.50M |
| March 31, 2024 | -38.44M |
| December 31, 2023 | -46.03M |
| September 30, 2023 | -52.01M |
| June 30, 2023 | -52.33M |
| March 31, 2023 | -55.50M |
| December 31, 2022 | -45.49M |
| September 30, 2022 | -42.45M |
| Date | Value |
|---|---|
| June 30, 2022 | -39.31M |
| March 31, 2022 | -27.98M |
| December 31, 2021 | -19.90M |
| September 30, 2021 | -12.89M |
| June 30, 2021 | -6.943M |
| March 31, 2021 | -4.636M |
| December 31, 2020 | -5.563M |
Free Cash Flow Range, Past 5 Years
-55.50M
Minimum
Mar 2023
-4.636M
Maximum
Mar 2021
-32.73M
Average
-39.31M
Median
Jun 2022
Free Cash Flow Benchmarks
| Stryker Corp | 3.205B |
| Perspective Therapeutics Inc | -24.58M |
| Retractable Technologies Inc | 4.325M |
| Xtant Medical Holdings Inc | -17.52M |
| Catheter Precision Inc | -7.444M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.90M |
| Cash from Investing (Quarterly) | 22.43M |
| Cash from Financing (Quarterly) | 0.311M |
| Free Cash Flow Per Share (Quarterly) | -0.2517 |
| Free Cash Flow to Equity (Quarterly) | -15.70M |
| Free Cash Flow Yield | -11.68% |